IMCR - Immunocore Holdings plc

QQQ $ 439.97 $ 4.77 (1.1 %)

DIA $ 388.40 $ 1.68 (0.43 %)

SPY $ 516.34 $ 5.28 (1.03 %)

TLT $ 90.16 $ 0.35 (0.39 %)

GLD $ 215.21 $ 2.24 (1.05 %)

Previous Close

$ 61.91

Open

$ 60.25

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 59.89 - $ 62.70

52 Week Range

$ 42.21 - $ 76.98

Volume

473,254

Average Volume

Market Cap

3.03B

Beta (5Y Monthly)

$ 0.68

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
1	02-28-2024	12-31-2023	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Where Immunocore Hldgs Stands With Analysts
04/29/2024 15:01:45

Leerink Partners Initiates Coverage On Imm...
04/29/2024 13:01:07

Leerink Partners analyst Jonathan Chang initiates coverage on Immunocore Hldgs (NASDAQ:IMCR) with a Outperform rating and an...

Guggenheim Reiterates Buy on Immunocore Hl...
04/23/2024 16:57:50

Guggenheim analyst Michael Schmidt reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $92 price target.

Immunocore Hldgs Stock: A Deep Dive Into A...
04/11/2024 13:00:17

Needham Reiterates Buy on Immunocore Hldgs...
04/11/2024 10:40:06

Needham analyst Gil Blum reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $81 price target.

Immunocore Says Selling Shareholders May O...
04/05/2024 20:39:37

- SEC Filing On April 5, 2024, Immunocore Holdings plc (the "Company") filed a prospectus supplement (the "Prospec...

JP Morgan Maintains Overweight on Immunoco...
03/21/2024 17:46:15

JP Morgan analyst Jessica Fye maintains Immunocore Hldgs (NASDAQ:IMCR) with a Overweight and raises the price target from $6...

Immunocore Filed For Mixed Shelf Up To $25...
03/21/2024 10:07:28

HC Wainwright & Co. Reiterates Buy on Immu...
03/06/2024 13:17:54

HC Wainwright & Co. analyst Patrick Trucchio reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $90 pric...

Mizuho Maintains Buy on Immunocore Hldgs, ...
03/05/2024 13:00:01

Mizuho analyst Graig Suvannavejh maintains Immunocore Hldgs (NASDAQ:IMCR) with a Buy and raises the price target from $86 to...

Key Takeaways From Immunocore Hldgs Analys...
02/29/2024 16:00:31

Oppenheimer Reiterates Outperform on Immun...
02/29/2024 15:41:15

Oppenheimer analyst Justin Kim reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Outperform and raises the price target from ...

Canaccord Genuity Maintains Hold on Immuno...
02/29/2024 15:19:10

Canaccord Genuity analyst Bill Maughan maintains Immunocore Hldgs (NASDAQ:IMCR) with a Hold and raises the price target from...

Needham Reiterates Buy on Immunocore Hldgs...
02/29/2024 10:07:31

Needham analyst Gil Blum reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $81 price target.

Immunocore Hldgs Q4 GAAP EPS $(0.40) Misse...
02/28/2024 12:38:34

Immunocore Hldgs (NASDAQ:IMCR) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(...

Earnings Scheduled For February 28, 2024
02/28/2024 11:24:02

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenu...

Immunocore Hldgs's Earnings: A Preview
02/27/2024 16:01:57

Immunocore Inks Clinical Trial Collaborati...
02/22/2024 12:13:29

The company will investigate Immunocore's ImmTAC bispecific TCR (T cell receptor) candidate targeting PRAME HLA-A02, IMC-F1...

Mizuho Maintains Buy on Immunocore Hldgs, ...
02/16/2024 23:52:56

Mizuho analyst Graig Suvannavejh maintains Immunocore Hldgs (NASDAQ:IMCR) with a Buy and raises the price target from $72 to...

DELFI Collaborates With Immunocore Holding...
02/01/2024 14:11:32